Table of Contents

Total Page:16

File Type:pdf, Size:1020Kb

Table of Contents Problem-Based Clinical Cases Obstetrics and Gynecology Rotation Gyn Cases Updated December 2004 OB Cases Updated June 2005 By Dr. Manisha Patel Table of Contents Section I: General Gynecology Page 4. Breast Disorders..................................................................................................................................... 1 5. Contraception ......................................................................................................................................... 2 7. Dysmenorrhea........................................................................................................................................ 3 8. Dyspareunia ........................................................................................................................................... 5 9. Ectopic Pregnancy.................................................................................................................................. 8 10. Enlarged Uterus...................................................................................................................................... 9 19. Menorrhagia ......................................................................................................................................... 10 23. Pelvic Relaxation .................................................................................................................................. 12 25. Postmenopausal Bleeding.................................................................................................................... 12 26. Postmenopausal Pelvic Mass............................................................................................................... 13 30. Premenopausal Pelvic Mass ................................................................................................................ 15 31. Premenstrual Syndrome....................................................................................................................... 16 33. Prepubertal Pelvic Mass....................................................................................................................... 17 38. Rape Victim .......................................................................................................................................... 17 44. Sterilization........................................................................................................................................... 19 47. Urinary Incontinence............................................................................................................................. 20 49. Vaginal Discharge / Itching................................................................................................................... 21 50. Vulvar Lesions...................................................................................................................................... 22 51. Preventative Care and Routine Screening............................................................................................ 23 Section II: Endocrinology and Fertility 15. Hirsutism/Virilization ............................................................................................................................. 24 18. Menopause........................................................................................................................................... 24 28. Precocious Puberty .............................................................................................................................. 25 35. Primary Amenorrhea ............................................................................................................................ 27 36. Primary Infertility................................................................................................................................... 30 41. Secondary Amenorrhea........................................................................................................................ 32 42. Secondary Infertility .............................................................................................................................. 34 Section III: Gynecologic Oncology 2. Abnormal Pap Smear ........................................................................................................................... 35 22. Ovarian Cancer .................................................................................................................................... 38 46. Trophoblastic Disease .......................................................................................................................... 41 Section IV: Infectious Disease 40. Salpingitis ............................................................................................................................................. 44 43. Sexually Transmitted Diseases ............................................................................................................ 45 Section V: Prenatal Care 3. Anemia in Pregnancy ........................................................................................................................... 48 6. Discrepant Fundal Size ........................................................................................................................ 49 11. Fetal Demise ........................................................................................................................................ 51 13. First Trimester Bleeding ....................................................................................................................... 51 14. Glucose Intolerance In Pregnancy........................................................................................................ 54 16. Hypertension in Pregnancy................................................................................................................... 57 17. Isoimmunization.................................................................................................................................... 60 20. Multiple Gestation................................................................................................................................. 61 32. Prenatal Diagnosis ............................................................................................................................... 63 45. Third Trimester Bleeding ...................................................................................................................... 64 48. Urinary Tract Infection in Pregnancy .................................................................................................... 66 Section VI: Obstetrics 1. Abnormal Labor .................................................................................................................................... 67 12. Fetal Distress ....................................................................................................................................... 69 21. Operative Obstetrics............................................................................................................................. 71 24. Post Dates............................................................................................................................................ 72 27. Postpartum Hemorrhage ...................................................................................................................... 74 29. Premature Rupture of Membranes ....................................................................................................... 76 34. Preterm Labor....................................................................................................................................... 78 37. Puerperal Infection ............................................................................................................................... 79 39. Rectovaginal Fistula ............................................................................................................................. 80 OB/GYN Problem-Based Clinical Cases 1998 Section 1: General Gynecology Section I: General Gynecology 4. Breast Disorders: 49 year-old Jean, G3 P2 Ab1, presents at your office complaining of a left breast lump. Your examination confirms a right breast upper outer quadrant 3 cm discrete, nontender, cystic mass. DDX: 1. Fibrocystic DZ -Most Common Breast Disease -Tender with hyperplastic changes -due to decreased progesterone or increased estrogen -Get a mammogram to rule out cancer -FNA to help in diagnosis -Provera, Tamoxifen, Paclodel to treat, diuretic to decrease edema 2. Fibroadenoma -Most Common Benign Tumor -Well circumscribed and freely moveable -increased with pregnancy; regress with menopause -Treatment involves surgical excision -Usually found in females < 30 3. Intraductal papilloma -usually develops just before or during menopause -presents with bloody discharge -excisional biopsy of involved duct 4. Mammary duct ectasia (Comedomastitis, Plasma Cell Mastitis) -Common in 40’s -presents with nipple discharge -presents with pain and tenderness (due to dilation of the ducts ) -chronic intraductal and periductal inflammation 5. Galactocele -Ductal obstruction -milky thick discharge 6. Carcinoma - 90% ductal; 10% lobular (often bilateral) - Paget’s 3% arises in secretory dusts and skin of the areola - PM women have a greater chance of being hormone receptor + which is associates with a better prognosis - most important prognosticator is axillary
Recommended publications
  • Placenta Increta at 14 Weeks with Subsequent Hysterectomy: a Case Report Abigail E Collett1*, Jean Payer1 and Xuezhi Jiang1,2
    ISSN: 2378-3656 Collett et al. Clin Med Rev Case Rep 2018, 5:225 DOI: 10.23937/2378-3656/1410225 Volume 5 | Issue 7 Clinical Medical Reviews Open Access and Case Reports CASE REPORT Placenta Increta at 14 Weeks with Subsequent Hysterectomy: A Case Report Abigail E Collett1*, Jean Payer1 and Xuezhi Jiang1,2 1Departments of OB/GYN, The Reading Hospital of Tower Health System, Reading, USA Check for updates 2Departments of OB/GYN, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, USA *Corresponding author: Abigail E Collett, DO., Department of OB/GYN-R1, The Reading Hospital of Tower Health, P.O. Box: 16052, Reading, Philadelphia, PA 19612-6052, USA, Tel: 484-628-8827, Fax: 484-628-9292, E-mail: Abigail.collett@ towerhealth.org Abstract transvaginal ultrasound which showed heterogeneous myo- metrium and a heterogeneous mass-like solid and cystic Background: Abnormal placental implantation (API) is an appearing area in the lower uterine segment. A total ab- uncommon obstetrical phenomenon that is associated with dominal hysterectomy, bilateral salpingectomy and cystos- significant maternal morbidity. Typically, the diagnosis of copy were performed. Intra-operative evaluation revealed a API is made at the time of delivery in the third trimester. firm protruding tissue mass in the left anterior lower uterine However there are reports of API presenting in the second segment that was found to be placenta increta or more on trimester, and rarely in the first trimester. Cesarean Scar final pathology. The patient recovered appropriately during Pregnancy (CSP) can be considered a subset of API. Early her hospital stay and was discharged in stable condition.
    [Show full text]
  • Gestational Trophoblastic Disease Early Detection, Diagnosis, and Staging Detection and Diagnosis
    cancer.org | 1.800.227.2345 Gestational Trophoblastic Disease Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. ● Can Gestational Trophoblastic Disease Be Found Early? ● Signs and Symptoms of Gestational Trophoblastic Disease ● How Is Gestational Trophoblastic Disease Diagnosed? Staging After a cancer diagnosis, staging provides important information about the extent of cancer in the body and anticipated response to treatment. ● How Is Gestational Trophoblastic Disease Staged? Questions to Ask About Gestational Trophoblastic Disease Here are some questions you can ask your cancer care team to help you better understand your diagnosis and treatment options. ● What Should You Ask Your Doctor About Gestational Trophoblastic Disease? 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Can Gestational Trophoblastic Disease Be Found Early? Most cases of gestational trophoblastic disease (GTD) are found early during routine prenatal care. Usually, a woman has certain signs and symptoms, like vaginal bleeding, that suggest something may be wrong. (See Signs and Symptoms of Gestational Trophoblastic Disease.) These problems will prompt the doctor to look for the cause of the trouble. Often, moles or tumors cause swelling in the uterus that seems like a normal pregnancy. But a doctor can usually tell that this isn't a normal pregnancy during a routine ultrasound exam. A blood test for HCG (human chorionic gonadotropin can also show something abnormal. This substance is normally elevated in the blood of pregnant women, but it may be very high if there is GTD.
    [Show full text]
  • Culdocentesis in Diagnosis of Disturbed Ectopic Pregnancy Still a Useful Procedure in Developing Countries
    CULDOCENTESIS IN DIAGNOSIS OF DISTURBED ECTOPIC PREGNANCY STILL A USEFUL PROCEDURE IN DEVELOPING COUNTRIES Pages with reference to book, From 5 To 6 Tasneem Aslam Tariq ( Department of Obstetrics and Gynaecology, Jinnah Postgraduate Medical Centre, Karachi. ) Razia Korejo ( Department of Obstetrics and Gynaecology, Jinnah Postgraduate Medical Centre, Karachi. ) ABSTRACT Over a period of 5 years culdocentesis was carried out in 156 cases of suspected ectopic pregnancy using needle aspiration through the pouch of Douglas. The result was positive in 134 cases, with 131 being true positive and 3 false positive. In 22 cases the result was negative, 6 of which were false negative. It is concluded that culdocentesis is an effective method of diagnosing disturbed ectopic pregnancy (JPMA 42: 5, 1992). INTRODUCTION Ectopic pregnancy, a clinical diagnosis in majority of cases is infrequently seen in our hospital. Since it can present with varied symptoms, diagnosis can be difficult in some cases. To increase the accuracy rate of preoperative diagnosis in suspected cases of ectopic pregnancy, various diagnostic procedures have been employed over the years. The purpose of this study was to evaluate the efficacy of culdocentesis for the diagnosis of ectopic pregnancy. PATIENTS AND METHOD The present study included 156 suspected cases of ectopic pregnancy admitted to the Department of Obstetrics and Gynaecology between January, 1985 to December 1989. Culdocentesis was done in the operating theatre under aseptic precautions with or without general anaesthesia depending on the certainty of the diagnosis. Urinary bladder was catheterized and gentle bimanual vaginal examination was done to confirm the previous vaginal findings. Sims speculum was introduced in the vagina and posterior lip of cervix was held gently with a Vulsellum forceps, pulled upwards and forwards exposing the posterior fornix.
    [Show full text]
  • Women's Health Course Guide
    Course Guide for Women’s Health 1 Approach to the Patient The OB/GYN History Rationale: A gynecological evaluation is an important part of primary health care and preventive medicine for women. A gynecological assessment should be a part of every woman’s general medical history and physical examination. Certain questions must be asked of every woman, whereas other questions are specific to particular problems. To accomplish these objectives, optimal communication must be achieved between patient and physician. The student will demonstrate the ability to: A. Perform a thorough obstetric-gynecologic history as a portion of a general medical history, including: 1. Chief complaint 2. Present illness 3. Menstrual history 4. Obstetric history 5. Gynecologic history 6. Contraceptive history 7. Sexual history 8. Family history 9. Social history B. Interact with the patient to gain her confidence and to develop an appreciation of the effect of her age, racial and cultural background, and economic status on her health; C. Communicate the results of the obstetric-gynecologic and general medical history by well-organized written and oral reports. The OB/GYN Examination Rationale: An accurate examination complements the history, provides additional information and helps determine diagnosis and guide management. It also provides an opportunity to educate and reassure the patient. The student will demonstrate the ability to: A. Interact with the patient to gain her confidence and cooperation, and assure her comfort and modesty B. Perform a painless obstetric-gynecologic examination as part of a woman’s general medical examination, including: 1. Breast examination 2. Abdominal examination 3. Complete pelvic examination 4.
    [Show full text]
  • A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
    ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction ..............................................................................................................
    [Show full text]
  • Partial Hydatidiform Molar Pregnancy
    DIAGNOSIS AT A GLANCE Marion-Vincent Mempin, MD, MSc; Poonam Desai, DO; Nadia Maria Shaukat, MD, RDMS, FACEP Partial Hydatidiform Molar Pregnancy Case partial molar pregnancy. A 26-year-old gravida 3, para 2-0-0-2, aborta 0 whose last An obstetric consultation was made and the patient menstrual period was 15 weeks 5 days, presented to the was taken to the operating room the following day for ED with complaints of mild vaginal spotting, which she a dilation and curettage (D&C) procedure. She was dis- first noted postcoitally the previous day. The patient de- charged home the next day without complications. The nied fatigue, lightheadedness, dyspnea, abdominal pain, products of conception were sent to pathology, and nausea, or vomiting. confirmed a triploid karyotype and p57 trophoblastic Physical examination revealed a well-appearing pa- immunopositivity, diagnostic of a partial hydatidiform tient with normal vital signs. The abdomen was soft and mole. nontender, and the fundus was palpable at the level of the umbilicus. A speculum examination was unremarkable, Discussion with normal external genitalia, a closed cervical os, no Hydatidiform moles are a subset of abnormal pregnan- adnexal masses or tenderness, and no blood in the vagi- cies termed gestational trophoblastic disease (GTD). nal vault. Laboratory studies were significant for a serum The two greatest risk factors for GTD are previous GTD beta human chorionic gonadotropin (beta-hCG) of 7,442 and extremis of maternal age.1 Patients often present mIU/mL (reference range for 15 weeks: 12,039-70,971 mIU/ mL). The patient was Rh posi- tive with a stable hematocrit.
    [Show full text]
  • Types and Efficacy of Diagnostic Modalities of Ectopic Pregnancy
    Jebmh.com Original Research Article Types and Efficacy of Diagnostic Modalities of Ectopic Pregnancy Pavani Pinjala1 1Department of Obstetrics and Gynaecology Mahavir Institute of Medical Sciences, Vikarabad, Hyderabad, Telangana, India. ABSTRACT BACKGROUND Ectopic pregnancy is not only the gynaecologist’s most critical emergency but also Corresponding Author: one of the major problems because of its difficulties in diagnosis, increased risks Dr. Pavani Pinjala, of mortality, and its profound implications with regard to future reproductive Block – D - 206, Vazhraa Nirmaan Pushpak Apartments, performance. We wanted to study the types and accuracy of various diagnostic Blooming Dale Road, Nizampet, modalities, and effect of various management modalities of ectopic pregnancy. Hyderabad – 500090, Telangana, India. E-mail: [email protected] METHODS This study was conducted at Meenakshi Medical College Hospital and Research DOI: 10.18410/jebmh/2020/568 Institute, Kanchipuram, for a period of 32 months from May 2010 to October 2012. During the same period, there were 2602 reported pregnancies. How to Cite This Article: Pinjala P. Types and efficacy of diagnostic modalities of ectopic RESULTS pregnancy. J Evid Based Med Healthc The incidence of ectopic pregnancy in the study is 15.3 / 1000 reported 2020; 7(47), 2767-2771. DOI: pregnancies. The incidence of ectopic pregnancy in patients with prior abdominal 10.18410/jebmh/2020/568 surgery was 86.6 %. Only 77.5 % patients gave history of typical amenorrhea. Submission 20-08-2020, 22.5 % patients gave history suggestive of atypical amenorrhoea. It was noted Peer Review 28-08-2020, that 55 % cases presented as tubal rupture, 7.5 % as tubal abortion, 35 % cases Acceptance 05-10-2020, presented with intact tubal pregnancy and 2.5 % cases presented as ovarian Published 23-11-2020.
    [Show full text]
  • Gestational Trophoblastic Disease
    4/12/17njm Gestational trophoblastic disease Background Gestational trophoblastic disease (GTD) is a spectrum of tumors with a wide range of biologic behavior and potential for metastases. GTD refers to both the benign and malignant entities of the spectrum and include hydatidiform mole, invasive mole, choriocarcinoma, and placental site trophoblastic tumor. The last three are termed gestational trophoblastic tumors (GTT); all may metastasize and are potentially fatal if untreated. The incidence of hydatidiform mole varies in different regions of the world, but has been falling. In North America the incidence is approximately 0.6 to 1.1 per 1000 pregnancies; the rate is approximately three times higher in Asia. Choriocarcinoma in North America occurs in one of every 20,000 to 40,000 pregnancies. The risk of repeat molar pregnancy in a conception following one molar pregnancy (complete, partial, or persistent GTN) is approximately 1 percent, which is increased compared with the 1:1000 risk of molar gestation in the general population. Therefore, ultrasound should be obtained in the late first trimester of subsequent pregnancies to confirm normal fetal development. Additionally, an hCG level should be obtained six weeks after completion of subsequent pregnancies to rule out occult choriocarcinoma. (see Management of Subsequent Pregnancies, below) Routine pathologic evaluation of the placenta, while recommended in the past, is not necessary. However, products of conception should be evaluated by a pathologist following any spontaneous or
    [Show full text]
  • Gynecology Rotation Goals
    Gynecology Rotation Goals: The resident will be competent in caring for the female patient in the areas of contraceptive counseling, maternity care, labor and delivery and female reproductive diseases and gynecologic conditions. This requires the application of their knowledge and skills in ascertaining the signs, symptoms and laboratory abnormalities of the ill adult patient. Knowledge: Objective: Upon completion of the training the resident will demonstrate the following competencies. 1. The unique modes of presentation of female patient, including altered and nonspecific presentations of diseases. 2. The processes and communication required for the safe transition of patients from one clinical setting to another. 3. The relationship between value quality, cost and incorporating patient wishes into optimal health care. 4. The access and interpretation of data, images and other information from available clinical information systems. 5. The clinical practices and interventions that improve patient safety and the effects of recommended interventions across the continuum of care. 6. Gynecology: (MK, PC) a. Normal Female development b. Disease prevention/health promotion and periodic health evaluation c. Physiology of menstruation d. Abnormal uterine bleeding e. Gynecologic problems of children f. Infections and diseases of the female reproductive and urinary systems g. Breast health and diseases of the breast h. Sexual assault i. Domestic violence j. Trauma to the reproductive system k. Pelvic pain l. Benign and malignant neoplasms of the female reproductive system m. Menopause and geriatric gynecology n. Indication for surgical intervention o. Cervical lesions and abnormal cytology p. Ectopic-pregnance 7. Consultation and referral: (MK, PC, ICS) a. Women’s health care delivery systems b.
    [Show full text]
  • Molar Pregnancy with Normal Viable Fetus Presenting with Severe Pre-Eclampsia: a Case Report Freddie Anak Atuk* and Juliana Binti Mohamad Basuni
    Atuk and Basuni Journal of Medical Case Reports (2018) 12:140 https://doi.org/10.1186/s13256-018-1689-9 CASE REPORT Open Access Molar pregnancy with normal viable fetus presenting with severe pre-eclampsia: a case report Freddie Anak Atuk* and Juliana Binti Mohamad Basuni Abstract Background: While gestational trophoblastic disease is not rare, hydatidiform mole with a coexistent live fetus is a very rare condition occurring in 0.005 to 0.01% of all pregnancies. As a result of the rarity of this condition, diagnosis, management, and monitoring will remain challenging especially in places with limited resources and expertise. The case we report is an interesting rare case which presented with well-described complications; only a few similar cases have been described to date. Case presentation: We report a case of a 21-year-old local Sarawakian woman with partial molar pregnancy who presented with severe pre-eclampsia in which the baby was morphologically normal, delivered prematurely, and there was a single large placenta showing molar changes. Conclusion: Even though the incidence of this condition is very rare, recognizing and diagnosing it is very important for patient care and it should be considered and looked for in patients presenting with pre-eclampsia. Keywords: Partial molar, Normal viable fetus, Pre-eclampsia Background Case presentation Molar pregnancy is significantly more common in A 21-year-old local Sarawakian primigravida woman was extremes of age [1]. Hydatidiform mole has been recog- diagnosed as having severe pre-eclampsia at 28 weeks and nized as a clinical entity since the time of Hippocrates and was admitted for blood pressure stabilization and moni- has always aroused interest because of its wide spectrum toring.
    [Show full text]
  • ASCCP Clinical Practice Statement Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding Published: February 7, 2017
    ASCCP Clinical Practice Statement Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding Published: February 7, 2017 All women presenting with abnormal vaginal bleeding should receive evaluation of the cervix and vagina, which should include at minimum visual inspection (speculum exam) and palpation (bimanual exam). If cervical or vaginal lesions are noted, appropriate tissue sampling is recommended, which can include Pap testing in addition to biopsy with or without colposcopy. These recommendations concur with those of ACOG Practice Bulletin #128 and Committee Opinion #557.1,2 The purpose of this article is to remind clinicians that Pap testing, as a form of tissue sampling, can be an important part of the workup of abnormal bleeding, and can be performed even if the patient is not due for her next screening test if there is clinical concern for cancer. Due to confusion amongst clinicians that has come to our attention, we wish to highlight the distinction between recommendations for diagnosis of cervical abnormalities including cancer amongst women with abnormal bleeding and recommendations for screening for cervical cancer amongst asymptomatic women. Screening guidelines recommend Pap testing at 3 year intervals for women ages 21-29, and Pap and HPV co-testing at 5 year intervals between the ages of 30-65 (with continued Pap testing at 3 year intervals as an option). These evidence- based guidelines are designed to maximize the detection of pre-cancer and minimize colposcopies. In addition, clinical practice guidelines no longer support routine pelvic examinations for cancer screening in asymptomatic women as this has not been shown to prevent cancer deaths.3,4,5 Consequently, physicians now perform fewer pelvic exams.
    [Show full text]
  • Pregnancy Complicated with a Giant Endocervical Polyp
    Pregnancy complicated with a giant endocervical polyp Kirbas A, Biberoglu E, Timur H, Uygur D, Danisman N Zekai Tahir Burak Women's Health Education and Research Hospital, Ankara, Turkey Objective We report the case of a giant cervical polyp in a primigravid young women that was associated cervical funneling. Methods Case report. Results A 21 year old primigravid woman admitted to our clinic with suspicion of cervical incompetence at 22 weeks of gestation. She complained of light vaginal bleeding and a vaginal mass. She did not have any pain. Her past medical history was uneventful. A detailed abdominal 2D ultrasound scan was performed to verify the presence of the pregnancy and research for associated anomalies. The US scan showed a 22 week viable fetus. Additionally, there was funneling of the cervical canal and the cervical length was 22 mm (Figure 1). On vaginal examination, there was light bleeding and a large fragile mass protruding from the vagina (Figure 2). We detected that the mass originated from the anterior lip of the cervix and it was extending into the cervical canal (Figure 3). We performed simple polypectomy. The funneling of the cervical canal disappeared after the operation and cervical canal length was 31 mm. The final histopathological findings confirmed a benign giant cervical polyp. The pregnancy is progressing well with a normal cervical length and she is currently 34 weeks of gestation. There has been no recurrence. We have planned endometrial and cervical canal evaluation after delivery. Conclusion Cervical polyps less than 2cm are quite common in the female adult population.
    [Show full text]